94516 ⎘
Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems; Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2 Oxygen atoms
Sub-classes:1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF
#2INHIBITORS OF PARG
#31,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF
#4KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
#5HETEROCYCLIC DERIVATIVES AS CAMKK2 INHIBITORS
#6SUBSTITUTED FUSED BICYCLIC COMPOUNDS AS PARP INHIBITORS AND THE USE THEREOF
#7KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
#8TYRAMINE CONTAINING HYDROXYCINNAMIC ACID AMIDE DERIVATIVES AND METHODS OF USE THEREOF
#9HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF
#10Inhibitors of PARG
#11SMALL MOLECULE STING ANTAGONISTS
#12SUBSTITUTED QUINAZOLINYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
#13HETEROARYL COMPOUNDS AND USES THEREOF
#14KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
#152-OXOQUINAZOLINE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS
#16AZA-HETEROBICYCLIC INHIBITORS OF MAT2A AND METHODS OF USE FOR TREATING CANCER
#17NOVEL CDK 8/19 INHIBITORS
#18KRAS G12C inhibitors and methods of using the same
#19Therapeutic compounds as inhibitors of the orexin-1 receptor
#20Small molecule modulators of human sting
#21KRAS G12C inhibitors and methods of using the same
#22KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
#23Heteroaryl compounds and uses thereof
#24TYRAMINE CONTAINING HYDROXYCINNAMIC ACID AMIDE DERIVATIVES AND METHODS OF USE THEREOF
#25Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases
#26High stress resistant plant growth regulator and preparation method and use thereof
#27KRAS G12C inhibitors and methods of using the same
#28KRAS G12C inhibitors and methods of using the same
#29Imidazopyrazines and pyrazolopyrimidines and their use as AMPA receptor modulators
#30Heterocyclic compounds and use thereof in medicine and in cosmetics
#31Heteroaryl compounds and uses thereof
#32Heterobicyclic sphingosine 1-phosphate analogs
#33Therapeutic compounds as inhibitors of the orexin-1 receptor
#34Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases
#35Alkylene derivatives
#36Heterocyclic compound
#37Heteroaryl compounds and uses thereof
#38Substituted pyrido[2,3-d]pyrimidines as protein kinase inhibitors
#39Phosphatidylinositol 3-kinase inhibitors
#40Heterobicyclic sphingosine 1-phosphate analogs
#416-piperazinyl-3,4-dihydroquinazolin-2(1)-ones
#42Dihydroquinone derivatives of piperidine and piperazine
#43Heteroaryl compounds and uses thereof
#44COMPOUNDS FOR THE TREATMENT OF NEUROLOGIC DISORDERS
#45Bicyclic heterocyclic compound
#46BICYCLIC ORGANIC COMPOUNDS SUITABLE FOR THE TREATMENT OF INFLAMMATORY OR ALLERGIC CONDITIONS
#47Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias
#48Heterobicyclic sphingosine 1-phosphate analogs
#49Quinazolinediones and their use
#50TRPV1 antagonists
#51Process for the preparation of dihydroquinazolines
#52Phenylalanine derivatives
#53TRPV1 antagonists
#54Wnt pathway antagonists
#55Process for the preparation of dihydroquinazolines
#56Caspase inhibitors and uses thereof
#57Cysteine protease inhibitors
#58Modulation of chemosensory receptors and ligands associated therewith
#59Caspase inhibitors and uses thereof
#60Bicyclic androgen and progesterone receptor modulator compounds and methods
#61Phenylalanine derivatives
#62Quinazolinone derivatives as tubulin polymerization inhibitors
#63Fused heterocyclic compounds as inhibitors of potassium channel function
#64Benzoxazinone derivative
#65Pyrimidine derivatives
#66Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions
#67Bicyclic androgen and progesterone receptor modulator compounds and methods
#68Process for the preparation of dihydroquinazolines
#69Caspase inhibitors and uses thereof
#70Modulation of chemosensory receptors and ligands associated therewith
#71Compounds, Compositions, and Methods
#72Dipeptidyl peptidase inhibitors
#73Method and compositions for identifying anti-hiv therapeutic compounds
#74Quinazolinone and benzoxazinone derivatives and uses thereof
#75Spirocyclic derivatives
#76Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
#77Histone deacetylase inhibitors
#78Phenylalanine derivatives
#79Amino alcohol ligand and its use in preparation of chiral proparglic tertiary alcohols and tertiary amines via enantioselective addition reaction
#80Preventives/remedies for urinary disturbance
#81Non nucleoside reverse transcriptase inhibitors
#82Method and compositions for identifying anti-hiv therapeutic compounds
#83Pyrimidine derivatives
#84Preventives/remedies for urinary disturbance
#85Bicyclic androgen and progesterone receptor modulator compounds and methods
#86Quinazolinyl compounds as inhibitors of potassium channel function
#87Method and compositions for identifying anti-HIV therapeutic compounds
#88Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds
#89Preventives/remedies for urinary disturbance
#90Non nucleoside reverse transcriptase inhibitors
#91Quinazolinone and benzoxazinone derivatives and uses thereof
#92Substituted aryl amides
#93Phenylalanine derivatives
#94Piperidinyl and piperazinyl compounds substituted with bicyclo-heterocyclylalkyl groups useful as CCR3 receptor antagonists
#953,4-Dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
#96Inhibitors of p38
#97Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
#986-piperazinyl-3,4-dihydroquinazolin-2(1)-ones
#99Dihydroquinone derivatives of piperidine and piperazine